<DOC>
	<DOCNO>NCT01572350</DOCNO>
	<brief_summary>This clinical trial design investigate difference term efficacy ( mean change best correct visual acuity obtain 12 month treatment ) safety , 3 therapeutic estrategies non-tractional macular edema diabetic patient : ) laser alone ; b ) laser plus tiramcinolon ; c ) laser plus bevacizumab .</brief_summary>
	<brief_title>Safety Efficacy Triamcinolone Acetonide Combined With Laser , Bevacizumab Combined With Laser Versus Laser Alone Treatment Diffuse Non-tractional Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>To eligible , follow inclusion criterion must meet : 1 . Age ≥18 year sexes . Women childbearing age use adequate contraception method submit negative pregnancy test . 2 . Diagnosis diabetes mellitus type 1 type 2 ( document ADA WHO guideline ) serum HbA1c &lt; 11 % time randomization ( determination do last two month ) . 3 . Patient able give inform consent . 4 . Eye clear medium , pupil dilation patient able cooperate perform retinography , OCT fluorescein angiography . 5 . Patients clinically significant diabetic macular edema ; patient must least one : 5.1 ) retinal thicken within 500 μ center 5.2 ) hard exudate within 500 μ center associate adjacent retinal thicken 5.3 ) size retinal thickening least 1 area disc , part le 1 DD center . 6 . Patients diffuse diabetic macular edema . 7 . Patients tractional diabetic macular edema . A patient eligible follow exclusion criterion present : 1 . Women childbearing age use adequate contraceptive method . 2 . Pregnancy lactation . Pregnancy test perform start treatment . 3 . Chronic renal failure require dialysis kidney transplantation . 4 . Allergy drug include study . 5 . Systemic use steroid last 4 month . 6 . Patient intend change place residence within 3 year recruitment , whenever go area cover study . 7 . Blood pressure &gt; 180/110 . If blood pressure bring 180/110 antihypertensive treatment , patient become eligible . 8 . HbA1c &gt; 11 % current analysis do last 2 month . 9 . An ocular condition present , opinion investigator , visual acuity would improve resolution macular edema ( e.g. , foveal atrophy , pigmentary change , dense subfoveal hare exudate , nonretinal condition ) . 10 . An ocular condition present ( diabetes ) , opinion investigator , might affect macular edema alter visual acuity course study ( e.g. , vein occlusion , uveitis ocular inflammatory disease , neovascular glaucoma , IrvineGass Syndrome , etc . ) 11 . Substantial cataract , opinion investigator , likely decrease visual acuity 3 line 12 . History prior treatment intravitreal corticosteroid intravitreal antiangiogenic . 13 . History peribulbar steroid injection within 6 month prior randomization . 14 . History focal , grid panretinal photocoagulation within 4 month prior randomization . 15 . Need panretinal photocoagulation first 4 month treatment . 16 . History prior par plana vitrectomy . 17 . Major ocular surgery ( include cataract extraction , scleral buckle , vitrectomy , etc . ) within prior 6 month anticipate within next 6 month follow randomization . 18 . History YAG capsulotomy perform within 2 month prior randomization . 19 . Intraocular pressure &gt; 25mmHg . 20 . History openangle glaucoma ( either primary openangle glaucoma cause openangle glaucoma ; note : angleclosure glaucoma exclusion ) . A history ocular hypertension exclusion long ( 1 ) intraocular pressure &lt; 25 mmHg , ( 2 ) patient use one topical glaucoma medication , ( 3 ) recent visual field , perform within last 12 month , normal ( abnormality present visual field must attributable patient 's diabetic retinopathy ) , ( 4 ) optic disc appear glaucomatous . 21 . History cortisoneinduced glaucoma require IOPlowering treatment . 22 . History prior herpetic ocular infection . 23 . Exam evidence ocular toxoplasmosis . 24 . Aphakia . 25 . Presence pseudoexfoliation . 26 . Evidence external ocular infection , include : conjunctivitis , chalazion blepharitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>